
O Loze Suspension
Marketer
Biometrix Pharma
Salt Composition
Lactulose (3.35gm)
Overview O Loze Suspension
Lactulose oral suspension is a sugar-based medication employed in the management of constipation. Functioning as a laxative, it facilitates bowel movements by increasing water content in the stool. It's also indicated for hepatic encephalopathy, a liver condition characterized by cognitive impairment, tremors, and altered consciousness. Lactulose can be administered with or without food, strictly as prescribed by your physician. Consistent daily use at the same time(s) optimizes therapeutic effects. Dosage adjustments may occur based on response. Avoid exceeding the recommended dose; missed doses should not be doubled. Onset of action typically requires at least 48 hours. Consult your doctor if constipation persists beyond 72 hours. Nausea and vomiting are common, generally mild, and self-limiting. However, severe diarrhea and electrolyte imbalances represent potential serious side effects, necessitating immediate medical attention. Prior to commencing treatment, inform your physician of any existing diabetes or lactose intolerance. Prolonged use may require periodic blood tests to monitor electrolyte levels (e.g., potassium and sodium). Concurrent use of other laxatives is contraindicated. Pregnant or breastfeeding individuals should seek medical advice before use.
Uses of O Loze Suspension
Managing constipation and hepatic encephalopathy.
Major Benefits of O Loze Suspension:
Administer this medication precisely as your physician prescribes, adhering to both dosage and treatment duration. Always consult the product label for usage instructions prior to consumption. Use a measuring device for accurate dosing and take orally. Ensure thorough shaking before each use. O Loze Suspension can be ingested with or without food; however, consistent timing is recommended for optimal results.
Common Side effects of O Loze Suspension:
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
How to use O Loze Suspension:
Administer this medication according to your physician's prescribed dosage and schedule. Always consult the product label for instructions prior to consumption. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. O Loze Suspension can be ingested with or without food; however, consistent timing is recommended.
How O Loze Suspension works:
Osmosis within the bowel is the mechanism by which Loze Suspension softens stool. The increased intestinal water content facilitates easier bowel movements.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from combining O Loze Suspension with alcohol.
PregnancySAFE IF PRESCRIBED
The use of O Loze Suspension during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use O Loze Suspension without significant risk to their infants. Available human data indicates minimal risk to the nursing child.
DrivingSAFE
Driving ability is typically unaffected by O Loze Suspension.
KidneySAFE IF PRESCRIBED
The use of O Loze Suspension in individuals with kidney disease is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of O Loze Suspension in patients with liver impairment appears to pose minimal risk. Available evidence indicates that dose modification may not be necessary. Physician consultation is recommended.
What if you forget to take O Loze Suspension :
Omit any missed dose of O Loze Suspension; resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About O Loze Suspension
| Label | Value |
|---|---|
| Pharmaceutical Category | Artificial double sugar |
| Potential for Dependence | None. |
| Type of Treatment | Gastrointestinal system |
| Mechanism of Action | Osmotic agents for bowel evacuation. |
